Icon PLC CEO Steve Cutler to Retire; Barry Balfe to Take Over on Oct. 1
PorAinvest
jueves, 4 de septiembre de 2025, 8:59 am ET1 min de lectura
ICLR--
Mr. Balfe, who has been with ICON for over two decades, has been the Chief Operating Officer since January 2025. Prior to his appointment as COO, he served as President of Functional Services and then as President of Pharma Solutions. ICON’s Chair, Mr. Ciaran Murray, praised Mr. Balfe’s record of success in leadership roles within the company and noted that his appointment follows a comprehensive succession planning process.
Dr. Cutler, who has been with ICON for 14 years, thanked the board, executive team, employees, and customers for their support during his tenure. He expressed confidence in Mr. Balfe’s ability to lead ICON to further growth and success. Mr. Balfe, in turn, expressed his honor and excitement at the opportunity to lead ICON during a pivotal time in the industry, with a focus on accelerating the development of novel therapeutics and enhancing customer value through increased efficiency and innovation.
ICON plc employs approximately 39,900 people in 95 locations across 55 countries, as of June 30, 2025. The company is known for its healthcare intelligence and provides outsourced services to pharmaceutical, biotechnology, medical device, and government and public health organizations.
The press release includes forward-looking statements, which are subject to future events, risks, and uncertainties. These statements are based on current expectations and information available as of the date of the press release.
References:
[1] https://www.iconplc.com/news-events/press-releases/icon-announces-ceo-transition
[2] https://www.stocktitan.net/news/ICLR/icon-announces-ceo-8216goevjdy2.html
Icon PLC CEO Steve Cutler is retiring, with Barry Balfe, currently COO, set to succeed him on October 1. Cutler will continue as a non-executive director to assist with the transition. Balfe has spent over two decades with Icon and has been COO since December. He will join the board.
ICON plc (NASDAQ: ICLR), a leading clinical research organization, has announced the retirement of its CEO, Dr. Steve Cutler, and the appointment of Mr. Barry Balfe as his successor. The transition will take place on October 1, 2025, with Mr. Balfe assuming the role of CEO and joining the board. Dr. Cutler will continue to serve as a non-executive director to facilitate a smooth transition.Mr. Balfe, who has been with ICON for over two decades, has been the Chief Operating Officer since January 2025. Prior to his appointment as COO, he served as President of Functional Services and then as President of Pharma Solutions. ICON’s Chair, Mr. Ciaran Murray, praised Mr. Balfe’s record of success in leadership roles within the company and noted that his appointment follows a comprehensive succession planning process.
Dr. Cutler, who has been with ICON for 14 years, thanked the board, executive team, employees, and customers for their support during his tenure. He expressed confidence in Mr. Balfe’s ability to lead ICON to further growth and success. Mr. Balfe, in turn, expressed his honor and excitement at the opportunity to lead ICON during a pivotal time in the industry, with a focus on accelerating the development of novel therapeutics and enhancing customer value through increased efficiency and innovation.
ICON plc employs approximately 39,900 people in 95 locations across 55 countries, as of June 30, 2025. The company is known for its healthcare intelligence and provides outsourced services to pharmaceutical, biotechnology, medical device, and government and public health organizations.
The press release includes forward-looking statements, which are subject to future events, risks, and uncertainties. These statements are based on current expectations and information available as of the date of the press release.
References:
[1] https://www.iconplc.com/news-events/press-releases/icon-announces-ceo-transition
[2] https://www.stocktitan.net/news/ICLR/icon-announces-ceo-8216goevjdy2.html

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema



Comentarios
Aún no hay comentarios